Tuberculosis treatment adherence in the era of COVID-19

[1]  S. Swaminathan,et al.  Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery. , 2022, The New England journal of medicine.

[2]  Manju R. Agrawal,et al.  Non-adherence to anti-tubercular treatment during COVID-19 pandemic in Raipur district Central India , 2021, Indian Journal of Tuberculosis.

[3]  M. Shah,et al.  Real-world implementation of video-observed therapy in an urban TB program in the United States , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  A. Harris,et al.  Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January–March 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[5]  E. Hak,et al.  Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review. , 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  S. Atre,et al.  Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study , 2019, JMIR formative research.

[7]  E. Hak,et al.  Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. , 2018, The Journal of infection.

[8]  F. Raab,et al.  Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA , 2018, Emerging infectious diseases.

[9]  Samuel B Holzman,et al.  Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy , 2018, Open forum infectious diseases.

[10]  Jingtao Gao,et al.  Guidelines for treatment of drug-susceptible tuberculosis and patient care-2017 update , 2018 .

[11]  R. Chaisson,et al.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  P. Garner,et al.  Directly observed therapy for treating tuberculosis , 2015, The Cochrane database of systematic reviews.

[13]  M. Mirsaeidi,et al.  Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective , 2015, European Respiratory Journal.

[14]  Carla A. Winston,et al.  Reported tuberculosis in the United States, 2010 , 2004 .

[15]  R. Chaisson,et al.  Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Vital Hepatitis Std Aids,et al.  Reported tuberculosis in the United States 2013 , 2014 .

[17]  R. Z. Topić.  Latent tuberculosis infection , 2012 .